Correspondence Between Ca²⁺ and Calciuria, Citrate Level and PH of Urine in Pediatric Urolithiasis
Overview
Authors
Affiliations
Background: Hypercalciuria and hypocitraturia are considered the most important risk factors for urolithiasis. Citrate binds to urinary calcium to form a soluble complex which decreases the availability of ionized calcium (Ca(2+)) necessary for calcium oxalate formation and phosphate crystallization. The aims of this study were to assess the Ca(2+) fraction in relation to total calciuria, citraturia and urinary pH and to determine whether urinary Ca(2+) concentration is a helpful biomarker in metabolic evaluation of children with urolithiasis.
Methods: We collected 24-h urine samples from 123 stone-forming children and adolescents with hypocitraturia and from 424 healthy controls. Total calciuria (total calcium, Catotal), Ca(2+), pH, citrate, oxalate and Bonn Risk Index (BRI) were assessed and compared between the two groups.
Results: Total calciuria and Ca(2+) content were higher in stone-formers than in the healthy children. In both stone-formers and controls, Ca(2+) content was inversely related to citraturia and urinary pH, whereas the Ca(2+)/Catotal ratio differed slightly between the groups. A large variability in Ca(2+) level was found across individuals in both groups. The BRI increased with increasing calciuria and urine acidity.
Conclusions: Compared to controls, stone-formers with hypocitraturia demonstrated a higher urinary Ca(2+) concentration, but this was proportional to calciuria. The large individual variability in urinary Ca(2+) content limits its practical use in metabolic evaluation of children with urolithiasis. However, the Ca/Citrate ratio may be a useful clinical tool in evaluating children with urolithiasis.
Wang L, Wang K, Yang M, Yang X, Li D, Liu M Adv Sci (Weinh). 2023; 11(2):e2302574.
PMID: 37973550 PMC: 10787096. DOI: 10.1002/advs.202302574.
Isik G, Gundogan Bozdag P J Nephrol. 2023; 36(6):1599-1604.
PMID: 37160650 DOI: 10.1007/s40620-023-01638-4.
Pediatric stone disease: Current management and future concepts.
Onal B, Kirli E Turk Arch Pediatr. 2021; 56(2):99-107.
PMID: 34286317 PMC: 8269932. DOI: 10.5152/TurkArchPediatr.2021.20273.
Pediatric nephrolithiasis: a systematic approach from diagnosis to treatment.
Marra G, Taroni F, Berrettini A, Montanari E, Manzoni G, Montini G J Nephrol. 2018; 32(2):199-210.
PMID: 29680873 DOI: 10.1007/s40620-018-0487-1.
Urinary calcium excretion in children with monosymptomatic enuresis.
Korzeniecka-Kozerska A, Porowski T, Wasilewska A, Stefanowicz M Ir J Med Sci. 2014; 184(4):899-905.
PMID: 25354570 PMC: 4611000. DOI: 10.1007/s11845-014-1217-x.